Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Voyageur Pharmaceuticals is a Canadian pharmaceutical company specializing in the development and manufacturing of barium and iodine contrast media for the medical imaging industry. The company distinguishes itself through a vertically integrated "From the Earth to the Bottle" strategy, sourcing raw materials from its own mineral projects to mitigate supply chain risks. Its primary focus is on producing high-quality barium sulfate products, such as SmoothX, for gastrointestinal imaging. Additionally, Voyageur is expanding its portfolio to include iodine-based contrast agents for computed tomography and interventional radiology. By controlling the entire production process from mining to pharmaceutical manufacturing, the company aims to provide cost-competitive solutions to the global healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Voyageur Minerals.